[go: up one dir, main page]

AU5797899A - Pulmonary-adminstration of mineral ascorbates - Google Patents

Pulmonary-adminstration of mineral ascorbates

Info

Publication number
AU5797899A
AU5797899A AU57978/99A AU5797899A AU5797899A AU 5797899 A AU5797899 A AU 5797899A AU 57978/99 A AU57978/99 A AU 57978/99A AU 5797899 A AU5797899 A AU 5797899A AU 5797899 A AU5797899 A AU 5797899A
Authority
AU
Australia
Prior art keywords
adminstration
pulmonary
mineral ascorbates
ascorbates
mineral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57978/99A
Inventor
Jeffrey Zidichouski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxycal Laboratories Inc
Original Assignee
Oxycal Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxycal Laboratories Inc filed Critical Oxycal Laboratories Inc
Publication of AU5797899A publication Critical patent/AU5797899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU57978/99A 1999-08-31 1999-08-31 Pulmonary-adminstration of mineral ascorbates Abandoned AU5797899A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/019977 WO2001015777A1 (en) 1999-08-31 1999-08-31 Pulmonary-administration of mineral ascorbates

Publications (1)

Publication Number Publication Date
AU5797899A true AU5797899A (en) 2001-03-26

Family

ID=22273502

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57978/99A Abandoned AU5797899A (en) 1999-08-31 1999-08-31 Pulmonary-adminstration of mineral ascorbates

Country Status (2)

Country Link
AU (1) AU5797899A (en)
WO (1) WO2001015777A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718694B2 (en) * 1997-10-16 2010-05-18 Children's Hospital & Research Center At Oakland Compositions and methods for therapy for diseases characterized by defective chloride transport
WO2004080427A2 (en) * 2003-03-12 2004-09-23 Schneider Daniel J Method of preventing and treating infections that attack mucosa and assisting rehabilitation thereafter using topically applied ascorbic acid
JP4671092B2 (en) * 2003-11-20 2011-04-13 森重 文江 Virus infection prevention and countermeasures
WO2005123064A1 (en) * 2004-06-10 2005-12-29 Board Of Trustees Of Michigan State University Adrenergic complement inhaler comprising compounds such as ascorbates tocopherols or polycaboxylic acid chelators
GB2525626A (en) * 2014-04-29 2015-11-04 Alexander Francois Robert Templet Composition and method for inhalable nutritional element

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU1819138C (en) * 1987-07-15 1993-05-30 Юрий Викторович Востриков Method of treatment of nonspecific bronchopneumonia in calves
US5944012A (en) * 1996-03-25 1999-08-31 Pera; Ivo E. Method for dispensing antioxidant vitamins by inhalation background of the invention

Also Published As

Publication number Publication date
WO2001015777A8 (en) 2001-10-11
WO2001015777A1 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
AU2001266068A1 (en) Treatment of mineral substrates
AU3300599A (en) Per-method designation of security requirements
AU3791601A (en) Treatment of coal
AU4343500A (en) Use of azetidinone compounds
AU3867400A (en) Methods of using bioelastomers
AU1930301A (en) Valdecoxib compositions
AU2557500A (en) Methods of making compounds
AU1536799A (en) Bishydroxyureas as inhibitors of the 5-lipoxygenase
AU1290501A (en) Composition
AU1488501A (en) Methods of inhibiting metastasis
AUPQ137699A0 (en) Control of acidosis
AU6564600A (en) Copolymers of acryloyloxyalkylamino compounds
AU6690300A (en) Copolymers of acryloylaminoalkyl compounds
AUPQ885500A0 (en) Enhancement of products
AU2681500A (en) Rapidly-soluble compositions
AU4917499A (en) Refractory compositions
AU2656799A (en) Metal-thiols as imminomodulating agents
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU1788800A (en) Derivative of paroxetine
AUPP342298A0 (en) Hydraulic fastening of components
AU5490099A (en) Manufacture of alpha-olefins
AU5085300A (en) Compositions
AU1082701A (en) Short segments of dap-kinase
AU5797899A (en) Pulmonary-adminstration of mineral ascorbates
EP1218407A4 (en) Uses of kappa-conotoxin pviia

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase